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Abstract
Background: Descending pronociceptive pathways may be implicated in states of persistent pain. Paw skin incision is 
a well-established postoperative pain model that causes behavioral nociceptive responses and enhanced excitability 
of spinal dorsal horn neurons. The number of spinal c-Fos positive neurons of rats treated intrathecally with serotonin, 
noradrenaline or acetylcholine antagonists where evaluated to study the descending pathways activated by a surgical 
paw incision.
Results: The number of c-Fos positive neurons in laminae I/II ipsilateral, lamina V bilateral to the incised paw, and in 
lamina X significantly increased after the incision. These changes: remained unchanged in phenoxybenzamine-treated 
rats; were increased in the contralateral lamina V of atropine-treated rats; were inhibited in the ipsilateral lamina I/II by 
5-HT1/2B/2C (methysergide), 5-HT2A (ketanserin) or 5-HT1/2A/2C/5/6/7 (methiothepin) receptors antagonists, in the ipsilateral 
lamina V by methysergide or methiothepin, in the contralateral lamina V by all the serotonergic antagonists and in the 
lamina X by LY 278,584, ketanserin or methiothepin.
Conclusions: We conclude: (1) muscarinic cholinergic mechanisms reduce incision-induced response of spinal 
neurons inputs from the contralateral paw; (2) 5-HT1/2A/2C/3 receptors-mediate mechanisms increase the activity of 
descending pathways that facilitates the response of spinal neurons to noxious inputs from the contralateral paw; (3) 5-
HT1/2A/2C and 5-HT1/2C receptors increases the descending facilitation mechanisms induced by incision in the ipsilateral 
paw; (4) 5-HT2A/3 receptors contribute to descending pronociceptive pathways conveyed by lamina X spinal neurons; 
(5) α-adrenergic receptors are unlikely to participate in the incision-induced facilitation of the spinal neurons.
Background
Bulbospinal pathways descend to the spinal cord to either
inhibit (antinociceptive) or facilitate (pronociceptive) the
transmission of nociceptive inputs (for review see [1,2]).
The contribution of supraspinal areas in the control of
descending pronociceptive pathways was confirmed by
several studies. As examples, the lesion or neural block of
rostral ventromedial medulla (RVM) or periaqueductal
gray (PAG) reduces the hyperalgesia induced by spinal
nerve ligature [3,4], or intraplantar injection of formalin
[5,6] or mustard oil [7]. Furthermore, low intensity elec-
trical stimulation of, or low dose of glutamate into the
RVM facilitates the response of spinal nociceptive neu-
rons to noxious inputs, whereas high intensity electrical
stimulation or high dose of glutamate produces the oppo-
site effect [8].
Descending pronociceptive pathways may be impli-
cated in states of persistent pain [9,10] and elucidation of
their spinal mediation may be useful for discovery of new
antihyperalgesic drugs. Spinal serotonin produces anti-
nociception but may be pronociceptive as well (for review
see [11]). Also, spinal activation of α2-adrenergic recep-
tors is antinociceptive whereas activation of α1-adrener-
gic receptors is pronociceptive [12,13]. A spinal
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ing noradrenergic inputs has also been proposed and it
seems to be linked only with antinociception (for review
see [14]).
Surgical incision of a rat paw causes primary and sec-
ondary punctate hyperalgesia [15] and increases the
number of c-Fos positive neurons in the spinal cord [16],
an immunohistochemical method that allows the identifi-
cation of neurons activated by peripheral noxious stimu-
lation [17]. Although being a poorly understood problem,
very little effort has been dedicated toward research on
the spinal mediation of descending mechanisms of post-
incision pain, a model that may allow us to understand
mechanisms of sensitization caused by surgery and inves-
tigate new therapies for postoperative pain.
The present study was therefore undertaken to examine
the changes in the number of c-Fos positive neurons in
the spinal cord of rats treated intrathecally with antago-
nists of serotonin, noradrenaline or acetylcholine, to eval-
uate whether they contribute in the spinal mediation of
descending pronociceptive pathways activated by a surgi-
cal incision. The laminae I/II, V and X were systemati-
cally examined, since they are predominantly implicated
in the reception, processing and rostral transmission of
nociceptive information [11].
Results
Effects of intrathecal muscarinic cholinergic, α-adrenergic 
and serotonergic receptor antagonists on the number of 
Fos-immunoreactive neurons in the laminae I/II, and V of 
the rat spinal cord
The number of Fos-LI neurons was very low bilaterally in
laminae I/II (Figure 1) and V (Figure 2) of non-incised
and non-catheterized anesthetized rats (group A), and
was slightly and non-significantly increased in non-
incised anesthetized rats treated intrathecally with saline
(group AS). The number of positive neurons was greater
bilaterally in laminae I/II and V of incised rats treated
intrathecally with saline (group ASI), the effect being sig-
nificant at the ipsilateral laminae I/II and bilateral
lamina V.
The incision-induced increase in the number of Fos-LI
neurons in the ipsilateral laminae I/II of rats from the
group ASI was significantly less intense following methy-
sergide (30 μg/5 μl), and was not changed significantly by
atropine (30 μg/5 μl) or phenoxybenzamine (20 μg/5 μl)
(ANOVA: F5,26 = 24.64; P < 0.0001) (Figure 1a). Similar
results were found in the contralateral laminae I/II, but
the differences were not significant (ANOVA: F5,26 = 1.74;
P > 0.05) (Figure 1b).
The incision-induced increase in the number of Fos-LI
neurons in the ipsilateral lamina V of rats from the group
ASI was less intense after methysergide (30 μg/5 μl), and
was not changed by phenoxybenzamine (20 μg/5 μl) or
atropine (30 μg/5 μl) (ANOVA: F5,26 = 9.94; P < 0.0001)
(Figure 2a). Similar, but less intense effect occurred in the
contralateral lamina V of rats treated with methysergide
(30 μg/5 μl) or phenoxybenzamine (20 μg/5 μl) as com-
pared with rats from the group ASI, but it was signifi-
cantly more intense in the contralateral lamina V of rats
treated with atropine (30 μg/5 μl) (ANOVA: F5,26 = 9.68; P
< 0.0001) (Figure 2b).
Representative photomicrographs taken from sections
of the spinal cords of control and test rats are given in Fig-
Figure 1 Effects of intrathecal atropine, phenoxybenzamine or 
methysergide in the incision-induced Fos-like immunoreactivity 
in lamina I/II. The experiments utilized 4-8 non-incised and non-cath-
eterized anesthetized rats (A), non-incised and catheterized rats treat-
ed intrathecally with 5 μl of saline (AS), incised and catheterized rats 
treated intrathecally with 5 μl of saline (ASI), 30 μg/5 μl of atropine 
(ATR), 20 μg/5 μl of phenoxybenzamine (PBZ), or 30 μg/5 μl methyser-
gide (MET). Surgical incision of the right hind paw was performed 3 h 
after PBZ or 15 min after the remaining antagonists. The number of 
Fos-like immunoreactive (Fos-LI) cells/0.2 mm2 are shown for lamina I/
II of ipsilateral (a) or contralateral (b) spinal dorsal horn. Bars are mean 
± S.E.M. of the number of Fos-LI cells/0.2 mm2 found in three sections 
taken from each rat. P < 0.05 compared to ASI (*) or AS (#).
Figure 2 Effects of intrathecal atropine, phenoxybenzamine or 
methysergide in the incision-induced Fos-like immunoreactivity 
in lamina V. The experiments utilized 4-8 non-incised and non-cathe-
terized anesthetized rats (A), non-incised and catheterized rats treated 
intrathecally with 5 μl of saline (AS), incised and catheterized rats treat-
ed intrathecally with 5 μl of saline (ASI), 30 μg/5 μl of atropine (ATR), 20 
μg/5 μl of phenoxybenzamine (PBZ), or 30 μg/5 μl methysergide (MET). 
Surgical incision of the right hind paw was performed 3 h after PBZ or 
15 min after the remaining antagonists. The number of Fos-like immu-
noreactive (Fos-LI) cells/0.2 mm2 are shown for lamina V of ipsilateral 
(a) or contralateral (b) spinal dorsal horn. Bars are mean ± S.E.M. of the 
number of Fos-LI cells/0.2 mm2 found in three sections taken from 
each rat. P < 0.05 compared to A (+), ASI (*) or AS (#).
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Figure 3 Photomicrographs showing Fos-like immunoreactivity in rat spinal cord. Photomicrographs were taken from 40- μm thick sections 
and illustrate the expression of Fos-like immunoreactivity in laminae I-II (a), V (b), and X (c) of the spinal cord gray matter (L2/L3 level), 2 h after the 
plantar incision of the right hind paw. of non-catheterized anesthetized rats (A), non-incised and catheterized rats treated. intrathecally with saline 
(AS), and incised and catheterized rats treated intrathecally with saline (ASI), atropine (ATR = 30 μg/5 μl), phenoxybenzamine (PBZ = 20 μg/5. μl), meth-
ysergide (MET = 30 μg/5 μl), LY 278,584 (LY = 100 μg/5 μl), ketanserin. (KET = 30 μg/5 μl), or methiothepin (MEP = 1.5 μg/5 μl).
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tively.
Effects of intrathecal muscarinic cholinergic, α-adrenergic 
and serotonergic receptor antagonists on the number of 
Fos-immunoreactive neurons in the lamina X of the rat 
spinal cord
The number of Fos-LI neurons in lamina X was very
small in rats from group A and non-significantly higher in
rats from group AS (Figure 4). The hind paw incision also
induced a significant increase in the number of positive
cells in lamina X, as compared to rats from group AS
(ANOVA: F5,24 = 7.06; P < 0.0003). The hind paw incision-
induced increase in the number of Fos-LI neurons in lam-
ina X was slightly reduced by methysergide (30 μg/5 μl),
and slightly increased by atropine (30 μg/5 μl) or phe-
noxybenzamine (20 μg/5 μl), but all changes occurred in a
non significant manner. Representative photomicro-
graphs taken from sections of the spinal cords of control
and test rats are given in Figure 3c.
Effects of intrathecal antagonists of 5-HT receptor subtypes 
on the number of Fos-immunoreactive neurons in the 
laminae I, II, and V of the rat spinal cord
The number of Fos-LI neurons was very low in laminae I/
II (Figure 5) and V (Figure 6) of rats from group A, and
was slightly but non-significantly increased in rats from
group AS. The number of positive neurons was higher
bilaterally in laminae I/II and V of incised rats treated
with saline (group ASI), the effect being significant at the
ipsilateral laminae I/II and bilateral lamina V.
The incision-induced increase in the number of Fos-LI
neurons in the ipsilateral laminae I/II was significantly
reduced by methiothepin (1,5 μg/5 μl) or ketanserin (30
μg/5 μl), but was not changed by LY 278,584 (100 μg/5 μl)
(ANOVA: F5,30 = 24.77; P < 0.0001) (Figure 5a). However,
no significant difference was demonstrated in the con-
Figure 4 Effects of intrathecal atropine, phenoxybenzamine or 
methysergide in the incision-induced Fos-like immunoreactivity 
in lamina X. The experiments utilized 4-8 non-incised and non-cathe-
terized anesthetized rats (A), non-incised and catheterized rats treated 
intrathecally with 5 μl of saline (AS), incised and catheterized rats treat-
ed intrathecally with 5 μl of saline (ASI), 30 μg/5 μl of atropine (ATR), 20 
μg/5 μl of phenoxybenzamine (PBZ), or 30 μg/5 μl methysergide (MET). 
Surgical incision of the right hind paw was performed 3 h after PBZ or 
15 min after the remaining antagonists. The number of Fos-like immu-
noreactive (Fos-LI) cells/0.2 mm2 are shown for lamina X. Bars are mean 
± S.E.M. of the number of Fos-LI cells/0.2 mm2 found in three sections 
taken from each rat. P < 0.05 compared to AS (#).
Figure 5 Effects of intrathecal LY278,584, ketanserin or methio-
thepin in the incision-induced Fos-like immunoreactivity in lami-
na I/II. The experiments utilized 4-8 non-incised and non-catheterized 
anesthetized rats (A), non-incised and catheterized rats treated intrath-
ecally with 5 μl of saline (AS), incised and catheterized rats treated in-
trathecally with 5 μl of saline (ASI), 100 μg/5 μl of LY 278,584 (LY), 30 μg/
5 μl of ketanserin (KET) or 1,5 μg/5 μl of methiothepin (MEP). Surgical 
incision of the right hind paw was performed 15 min after each antag-
onist. The number of Fos-like immunoreactive (Fos-LI) cells/0.2 mm2 
are shown for lamina I/II of ipsilateral (a) or contralateral (b) spinal dor-
sal horn. Bars are mean ± S.E.M. of the number of Fos-LI cells/0.2 mm2 
found in three sections taken from each rat. P < 0.05 compared to ASI 
(*) or AS (#).
Figure 6 Effects of intrathecal LY278,584, ketanserin or methio-
thepin in the incision-induced Fos-like immunoreactivity in lami-
na V. The experiments utilized 4-8 non-incised and non-catheterized 
anesthetized rats (A), non-incised and catheterized rats treated intrath-
ecally with 5 μl of saline (AS), incised and catheterized rats treated in-
trathecally with 5 μl of saline (ASI), 100 μg/5 μl of LY 278,584 (LY), 30 μg/
5 μl of ketanserin (KET) or 1,5 μg/5 μl of methiothepin (MEP). Surgical 
incision of the right hind paw was performed 15 min after each antag-
onist. The number of Fos-like immunoreactive (Fos-LI) cells/0.2 mm2 is 
shown for lamina V of ipsilateral (a) or contralateral (b) spinal dorsal 
horn. Bars are mean ± S.E.M. of the number of Fos-LI cells/0.2 mm2 
found in three sections taken from each rat. P < 0.05 compared to ASI 
(*) or AS (#).
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(ANOVA: F5,30 = 2.02; P > 0.05) (Figure 5b).
The incision-induced increase in the number of Fos-LI
neurons in the ipsilateral lamina V was also reduced by
methiothepin (1,5 μg/5 μl), ketanserin (30 μg/5 μl) or LY
278,584 (100 μg/5 μl), but only the effect of methiothepin
was significant (ANOVA: F5,26 = 9.94; P < 0.0001) (Figure
6a). In contrast, ketanserin, LY 278,584 and mainly meth-
iothepin all reduced significantly the incision-induced
increase in the number of positive cells in the contralat-
eral lamina V (ANOVA: F5,30 = 7.27; P = 0.0001) (Figure
6b).
Representative photomicrographs taken from sections
of the spinal cords of control and test rats are given in Fig-
ure 3a and 3b for superficial and deep laminae, respec-
tively.
Effects of intrathecal antagonists of 5-HT receptor subtypes 
on the number of Fos-immunoreactive neurons in the 
lamina X of the rat spinal cord
The number of Fos-LI neurons in lamina X was very
small in rats from group A and was non-significantly
superior in rats from group AS (Figure 7). The hind paw
incision also induced a significant increase in the number
of positive cells in lamina X, as compared to rats from
group AS, the effect being significantly reduced by LY
278,584 (100 μg/5 μl), ketanserin (30 μg/5 μl) or methio-
thepin (1,5 μg/5 μl) (ANOVA: F5,28 = 9.26; P < 0.0001).
Representative photomicrographs taken from sections of
the spinal cords of control and test rats are given in Figure
3c.
Discussion
Fos protein is a product of the proto-oncogene c-Fos,
which is expressed in the neuronal nuclei few hours after
an appropriate stimulus [18]. The increase in the expres-
sion of Fos-LI neurons in spinal cord has been used as a
marker of the neuronal activity induced by noxious stim-
uli in various pain models [17]; for review see [19,20].
Although being a poorly understood problem, very little
effort has been dedicated toward research on the spinal
mediation of descending mechanisms of post-incision
pain, a model that may allow us to understand mecha-
nisms of sensitization caused by surgery and investigate
new therapies for postoperative pain.
The present study confirmed that a surgical incision in
a rat hind paw increased significantly the number of Fos-
LI neurons in the spinal dorsal horn laminae I/II ipsilat-
eral, and lamina V bilateral to the incised paw as shown
elsewhere [16,21,22].
Also, a significant increase in the number of Fos-LI
neurons were also found in the lamina X of the spinal
gray matter following the incision, as described elsewhere
subsequent to peripheral or visceral nociceptive inputs
[23].
Incision of a hind paw increases both the response of
spinal wide dynamic range cells to mechanical stimula-
tion [15] and the spontaneous activity of nociceptive pri-
mary afferents [24]. The model of incision pain differs
from inflammatory pain models [25,26], but the tissue
reactions to incision are likely to involve some inflamma-
tory responses to local injury [27].
Evidence that descending influences can affect spinal
phenomena induced by a paw incision includes the dem-
onstration that incision pain is further increased in rats
with lesion of dorsolateral funiculus [28], that conveys
descending pain inhibitory pathways [11], or electrolytic
lesion of the anterior pretectal nucleus [29], that partici-
pates in the activation of descending mechanisms of pain
control [30]; in the ipsilateral spinal cord, the incision-
induced increase in the number of Fos-LI neurons was
significantly reduced in the superficial lamina and signifi-
cantly increased in the deep lamina of animals previously
treated with bupivacaine in the contralateral anterior pre-
tectal nucleus [16]; finally, descending pathways are
known as the only sources of serotonin in the spinal cord
[2,11,31].
Acetylcholine, noradrenaline and serotonin modulate
noxious inputs processing in the spinal cord (for review
see [11]. Atropine, a non selective muscarinic receptor
Figure 7 Effects of intrathecal LY278,584, ketanserin or methio-
thepin in the incision-induced Fos-like immunoreactivity in lami-
na X. The experiments utilized 4-8 non-incised and non-catheterized 
anesthetized rats (A), non-incised and catheterized rats treated intrath-
ecally with 5 μl of saline (AS), incised and catheterized rats treated in-
trathecally with 5 μl of saline (ASI), 100 μg/5 μl of LY 278,584 (LY), 30 μg/
5 μl of ketanserin (KET) or 1,5 μg/5 μl of methiothepin (MEP). The num-
ber of Fos-like immunoreactive (Fos-LI) cells/0.2 mm2 are shown for 
lamina X. Surgical incision of the right hind paw was performed 15 min 
after each antagonist. Bars are mean ± S.E.M. of the number of Fos-LI 
cells/0.2 mm2 found in three sections taken from each rat. P < 0.05 
compared to ASI (*) or AS (#).
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the dose known to be effective against the neostigmine-
induced antinociception in rats [32].
Phenoxybenzamine, a non selective α-adrenergic
receptor antagonist was used here at 20 μg/rat, 2.5 fold
superior to the dose early shown to be effective against
glutamate-induced analgesia from the RVM of rats [33].
Nonetheless, neither the atropine nor the phenoxyben-
zamine changed the incision-induced increase in the
number of Fos-LI neurons in the laminae I/II, bilaterally,
ipsilateral lamina V, or in lamina X. Consequently, mus-
carinic and α-adrenergic receptors are unlikely to partici-
pate in mechanisms that facilitate the response of spinal
neurons to noxious inputs evoked by the incision. On the
contrary, the increase in the number of Fos-LI neurons in
the lamina V contralateral to the incised paw was signifi-
cantly greater in atropine- than in saline-treated rats. In
agreement to earlier studies [34-36], we interpret the
result as indirect evidence that a muscarinic cholinergic
mechanism responds to a surgical incision reducing the
response of spinal neurons to noxious inputs from the
contralateral paw. A possibility remains that the depres-
sion of c-Fos labeling is due to toxic effects of the antago-
nists used in the study. However, as far as we know, there
is no report showing that at the doses used in the study,
the intrathecal antagonists induces toxic effects against
spinal dorsal horn cells in rats.
Among the seven classes of serotonin receptors (5-HT1-
7) currently known (for review see [37]), at least three (5-
HT1/2/3/) were found in the spinal cord [38,39] and are
implicated in spinal pain processing [40-43]. The anti-
nociceptive effect of 5-HT may also occur via interaction
with spinal 5-HT4 receptors [44,45], but experiments
involving pharmacological blockade of these receptors
were not conducted in this study.
The increase in the number of Fos-LI neurons in the
lamina I/II ipsilateral to the incised paw was significantly
inhibited by antagonists for 5-HT1/2B/2C (methysergide),
5-HT2A (ketanserin) or 5-HT1/2A/2C/5/6/7 (methiothepin)
receptors, but was not changed by a 5-HT3 antagonist (LY
278,584). The same effect was also significantly inhibited
in the lamina V ipsilateral to the incised paw by methy-
sergide or methiothepin, but remained unchanged fol-
lowing ketanserin or LY 278,584. Therefore, 5-HT1/2A/2C
receptors in laminae I/II and 5-HT1/2Creceptors in lamina
V, but not 5-HT3 receptors in either laminae I/II or V, are
involved in the activity of a descending pathway that facil-
itates the response of spinal neurons to noxious inputs
induced by a surgical incision in the ipsilateral paw.
The significant increase in the number of Fos-LI neu-
rons in the contralateral lamina V was inhibited by all the
serotonergic antagonists used in the study. Thus, 5-HT1/
2A/2C/3 receptors contribute to the effect of serotonin in
the activity of a descending pathway that facilitates the
response of spinal neurons to noxious inputs induced by a
surgical incision in the contralateral paw. Finally, the
increase in the number of Fos-LI neurons in lamina X
was significantly inhibited by LY 278,584, ketanserin or
methiothepin, but not by methysergide. We then con-
clude that 5-HT2A/3 receptors contribute to the effects of
serotonin in a descending pronociceptive pathway con-
veyed by lamina X spinal neurons.
Altogether, these results support the involvement of
serotonin in descending mechanisms that facilitate the
response of spinal neurons to nociceptive inputs in the
spinal cord. Serotonergic nerve terminals found in the
spinal cord originate from supraspinal sources [2,11,31]
and, therefore, descending pathways utilizing serotonin
somehow excite nociceptive cells in the spinal cord while
a postoperative pain is in course. Bulbospinal influences
from the RVM contribute to facilitation of noxious inputs
and development of secondary hyperalgesia in persistent
inflammatory, neuropathic, and visceral pain models[46].
Primary and secondary hyperalgesia observed after a sur-
gical incision do not appear to be modulated by descend-
ing influences from the RVM, thus supporting the view
that incision pain involves different mechanisms com-
pared with inflammatory and neuropathic pain[47].
However, in this study Pogatzki et al., utilized rats 5 days
after RVM lesion and, therefore, it is possible that a struc-
ture located more rostrally assumes the control of the pri-
mary and secondary hyperalgesia observed after a
surgical incision. In fact, several other studies have shown
the involvement of descending pain pathways in this
model [29,30,48-51].
The spinal actions of serotonin has long been associ-
ated to suppression of the responses to nociceptive inputs
[52-54], but evidence has accumulated questioning
whether descending serotonergic pathways play an exclu-
sive spinal suppressive effect against nociceptive inputs
[53,55]. The activation of spinal serotonin receptors has
been associated with both pronociceptive and antinocice-
ptive effects depending on algesimetric test, drug dosage,
duration of the treatment and pathophysiological condi-
tion [56-58].
The spinal dorsal horn contains high concentrations of
5-HT1A, and 5-HT1B receptors [39,59], but the occurrence
of 5-HT1D receptors is possible [60,61]. The activation of
spinal 5-HT1A may result analgesia [62,63] (see also [64]),
or hyperalgesia [65,66], while the activation of spinal 5-
HT1B receptors produces antinociception [67,68].
The presence of spinal 5-HT2A [69,70], and 5-HT2C
receptors [71,72] has already been demonstrated. Stimu-
lation of spinal 5-HT2A receptors is pronociceptive
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inhibitory interneurons supports an antinociceptive role
for 5-HT [74,75]. The activation of spinal 5-HT2C recep-
tors excites neurons [55,76,77], and its distribution in the
spinal cord is compatible with a pronociceptive role of 5-
HT in the dorsal horn [12,78]. Conversely, 5-HT2C sites
on spinal inhibitory interneurons allow a potential anti-
nociceptive role for serotonin [79].
Studies have demonstrated that 5-HT3 receptors are
concentrated in superficial layers of the dorsal horn
[59,80] and a significant proportion is located on the ter-
minals of C fibres [12,81]. The activation of the 5-HT3
receptors depolarizes neurons in dorsal root ganglions
and, therefore, is expected to increase the transmitter
release from the primary afferent terminals into the spi-
nal cord (see [64]). In line with the present results, the
activation of spinal 5-HT3 receptors increases nocicep-
tion [62,82,83], and blockade of spinal 5-HT3 receptor
reduces the hypersensitivity of spinal dorsal horn neu-
rons of nerve-ligated rats [84]. A pronociceptive role for
5-HT3 receptors in the spinal cord following activation of
descending pronociceptive pathways has already been
proposed [84,85].
It is also noteworthy, that a direct facilitation by sero-
tonin of glutamatergic synapses has been demonstrated
in the spinal cord [86,87] and, therefore, this mechanism
may account for some of the excitatory effects of sero-
tonin found here.
There is evidence that a peripheral damage simultane-
ously triggers both descending inhibition and facilitation
onto both primary and secondary spinal hyperalgesic
mechanisms, but the balance for primary hyperalgesia is
different from the balance for secondary hyperalgesia (for
review see [48]).
Behavioral nociceptive responses of our animals were
not evaluated during this study but it may be assumed
that the increased number of Fos-LI neurons in the dorsal
horn ipsilateral to the incised paw essentially reflects pri-
mary hyperalgesia. By extension, a secondary hyperalge-
sia evoked by central sensitization may be assumed to
occur when the effect was observed in the contralateral
dorsal horn (see [88]). Therefore, our results show that
incision-induced primary and secondary hyperalgesias
seem to be spinally mediated by 5-HT1/2A/2C and 5-HT1/
2A/2C/3 receptors, respectively.
Few studies have accessed which neurotransmitters are
involved in the spinal processing of hyperalgesia in the
mode of post-incision pain. They have shown that nora-
drenergic receptors are involved in the spinal mediation
of descending inhibitory pathways in the primary hyper-
algesia of postoperative pain [29,49,51]. Few reports are
also available regarding secondary hyperalgesia after
post-incision pain [47,89-94] but, as far we know, none of
them have studied spinal neurotransmitters involved in
descending mechanisms.
Conclusions
In conclusion (Table 1), 5-HT1/2A/2C receptors in laminae
I/II and 5-HT1/2C receptors in lamina V contribute to the
effects of serotonin in descending pathway that facilitates
the response of spinal neurons to noxious inputs from the
ipsilateral paw (primary hyperalgesia?); 5-HT1/2A/2C/3
receptors mediate the effects of a descending pathway
that facilitates the response of spinal neurons to noxious
Table 1: Effects of antagonists in the incision-induced increase of Fos-like immunoreactivity in the rat spinal cord
Antagonists LI/LII LV LX
ipsi contra ipsi contra
Atropine 
(muscarinic)
- - - 9* -
Phenoxybenzami
ne (α-adrenergic)
- - - - -
Methysergide (5-
HT1/2B/2C)
|* - |# |# |#
LY 278,584 (5-HT3) - - - |* |*
Ketanserin (5-
HT2A)
|* - - |* |*
Methiothepin (5-
HT1/2A/2C/5/6/7)
|* - |* |* |*
Antagonists were injected intrathecally. Abbreviations: ipsi = ipsilateral and contra = contralateral to the incised hind paw; | = decrease and 
9 = increase of the effect produced by the incision on the Fos-like immunoreactivity. (*) Significantly different from intrathecal saline-treated 
incised rats. (#) Abolished the significance of the incision-induced increase of Fos-like immunoreactivity but did not differ significantly from 
intrathecal saline-treated incised rats.
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Page 8 of 11inputs from the contralateral paw (secondary hyperalge-
sia?); and 5-HT2A/3 receptors contribute to the effects of
serotonin in a descending pronociceptive pathway con-
veyed to lamina X spinal neurons. Finally, the study con-
firms that spinal muscarinic cholinergic mechanism
responds to a surgical incision reducing the response of




Male Wistar rats (200-250 g) were used in this study. Ani-
mals were housed two to a cage under controlled temper-
ature (22 ± 1°C) and on a 12-h light-dark cycle, with the
dark cycle beginning at 07:00 h, and had free access to
food and water. The experiments were approved by the
Commission of Ethics in Animal Research, Faculty of
Medicine of Ribeirão Preto, University of São Paulo
(Number 009/2004). The guidelines of the Committee for
Research and Ethical Issues of IASP [95] were followed
throughout the experiments.
Surgery
Each rat was anesthetized with halothane via a loose-fit-
ting, cone-shaped mask, and catheterization of the spinal
subarachnoid space was performed as described else-
where [96]. Briefly, a 20-gauge Weiss needle was intro-
duced through the skin into the L5-L6 intervertebral
space. The correct positioning of the needle was assured
by a typical flick of the tail or hind paw. A 12-mm length
of polyethylene tubing (PE tubing, o.d. = 0.4 mm, dead
space = 10 μl) was then introduced through the needle to
protrude 2.0 cm into the subarachnoid space in a cranial
direction. The needle was then carefully removed and the
tubing anchored to the back skin with a cotton thread
suture. Drug or saline was injected intrathecally soon
after the catheterization in a volume of 5 μl over a period
of 60 s, followed by 5 μl of sterile saline at the same rate to
flush the catheter. The plantar side of the right hind paw
was prepared with a 10% povidone-iodine solution 15-
min later. A 1-cm longitudinal incision was made with a
surgical blade, through the skin and fascia of the plantar
region, starting 0.5 cm from the proximal edge of the
heel, as described elsewhere [97]. The plantaris muscle
was elevated, but its origin and insertion were left intact.
After hemostasia, the skin was apposed with one single
suture of 5-0 nylon, and the animal was allowed to
recover in the home cage for a period of 2 h. The posi-
tioning of the intrathecal catheter was verified when the
spinal cord was removed for Fos immunohistochemistry.
Fos immunohistochemistry
The animals were sacrificed with an intraperitoneal over-
dose of sodium thiopental performed 2 h after the plantar
incision, and perfused transcardially with saline followed
by 4% paraformaldehyde in 0.1 M PBS, pH 7.4. The spinal
cord was removed, fixed for 2 h in paraformaldehyde and
stored for at least 48 h in 30% sucrose. The side ipsilateral
to the incised paw was marked with a little knife cut. The
samples were then frozen in Tissue Teck (Sakura®). Fos
immunohistochemistry was processed, as described else-
where [98], on 40 μm transverse sections obtained with a
cryostat (Leica CM 1850) from L2-L3 spinal cord seg-
ments. The tissue sections were successively washed and
incubated for 1 h in goat anti-rabbit biotinylated antibody
(1:400 in PBS; Vector Laboratories, Burlingame, CA).
They were then processed by the avidin-biotin immu-
noperoxidase method (Vectastain ABC kit, Vector Lab,
Burlingame, CA, U.S.A.), and then Fos-like immunoreac-
tivity (FLI) was revealed by the addition of chromogen
diaminobenzidin (Sigma).
All reactions were performed at room temperature.
Fos-like immunoreactivity was quantified using an image
analysis system (Leica, Quantimet 500, Leica Microsys-
tems Inc. Cambridge, UK) that identified and counted
immunostained neurons according to a gray level that
was empirically determined prior to analysis. The num-
ber of Fos-like immunoreactive (Fos-LI) neurons/section
was calculated as the mean of the three sections exam-
ined for each rat. For analysis of the laminar distribution
of Fos-LI neurons, the spinal cord gray matter was
divided into three regions (laminae I-II, V, and X). Assess-
ment of Fos-like immunoreactivity was conducted in a
blind manner.
The number of Fos-LI neurons per region on both the
ipsilateral and contralateral slides was counted in fixed
area sizes (0.2 mm2 for spinal cord laminae I/II, V or X),
using a software 9.0 image analysis system (W. Rasband,
National Institute of Health). Only rats showing catheter
tip positioned at the dorsal spinal cord were considered
for data analysis.
Drugs
Atropine sulfate, a non selective muscarinic cholinergic
antagonist, phenoxybenzamine hydrochloride, a non
selective α-receptor antagonist, methysergide, a 5-HT1/
2B/2C antagonist [99], ketanserin, a 5-HT2A antagonist
[100], methiothepin, a 5-HT1/2A/2C/5/6/7 antagonist [101],
and LY 278,584, a 5-HT3 antagonist [102,103], were pur-
chased from Sigma (St Louis, MO, USA) and diluted in
sterile isotonic saline at the moment of the injection.
Experimental design
All animals were anesthetized and allocated to one of
four experimental groups. A group for the overall control
of the experiment had non-incised and non-catheterized
anesthetized rats (group A), which were sacrificed 2 h
after the beginning of anesthesia. A group for control of
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Page 9 of 11the effects of intrathecal catheterization had non-incised
rats treated intrathecally with saline (5 μl) and were sacri-
ficed 2 h later (group AS). A group for control of the
effects of the hind paw incision had rats treated intrathe-
cally with saline and submitted to the surgical incision of
the right hind paw performed 15-min later (group ASI).
Test groups had rats submitted to paw incision carried
out 3 h after intrathecal phenoxybenzamine or 15-min
after methysergide, atropine, LY 278,584, ketanserin or
methiothepin. Animals from group ASI and test groups
were sacrificed 2 h after the incision.
Statistics
The mean (± SEM) of the number Fos-LI cells/0.2 mm2 of
3 sections from the spinal cord of 4 - 8 animals per group
was taken to allow comparisons among the different
treatments. Comparisons of groups were made using
one-way ANOVA followed by the Tukey's Multiple Com-
parison test. The level of significance was set at P < 0.05
in all cases.
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